Consolidated Statement Of Cash Flows

Solasia Pharma K.K. - Filing #7311866

Concept 2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
As at
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-04-01 to
2024-06-30
As at
2023-12-31
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
As at
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
As at
2022-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
-611,000,000 JPY
JPY
JPY
JPY
JPY
-611,000,000 JPY
JPY
JPY
-300,000,000 JPY
-437,000,000 JPY
JPY
-437,000,000 JPY
-196,000,000 JPY
JPY
JPY
JPY
JPY
JPY
Finance income
-3,000,000 JPY
-15,000,000 JPY
Finance costs
0 JPY
0 JPY
Share of loss (profit) of investments accounted for using equity method
2,000,000 JPY
3,000,000 JPY
Decrease (increase) in inventories
-15,000,000 JPY
-103,000,000 JPY
Other
19,000,000 JPY
-1,000,000 JPY
Subtotal
-473,000,000 JPY
-304,000,000 JPY
Interest received
0 JPY
0 JPY
Interest paid
0 JPY
0 JPY
Net cash provided by (used in) operating activities
-474,000,000 JPY
-330,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
0 JPY
0 JPY
Net cash provided by (used in) investing activities
0 JPY
0 JPY
Cash flows from financing activities
Proceeds from issuance of bonds
500,000,000 JPY
JPY
Redemption of bonds
-500,000,000 JPY
JPY
Proceeds from issuance of shares
692,000,000 JPY
1,000,000 JPY
Other
1,000,000 JPY
JPY
Net cash provided by (used in) financing activities
675,000,000 JPY
-23,000,000 JPY
Net increase (decrease) in cash and cash equivalents
200,000,000 JPY
-354,000,000 JPY
Cash and cash equivalents
942,000,000 JPY
728,000,000 JPY
453,000,000 JPY
803,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
13,000,000 JPY
3,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.